Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01937845 · ClinicalTrials.gov registry record

Evaluating the Health Outcomes of the Joslin Why WAIT Program

A clinical trial, sponsored by Joslin Diabetes Center.

Active
Registry status
110
Enrollment target

NCT01937845: Active study, sponsored by Joslin Diabetes Center.

NCT01937845 is a clinical trial that is active but no longer recruiting, run by Joslin Diabetes Center. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01937845 is active but no longer recruiting, sponsored by Joslin Diabetes Center.

ACTIVE NOT RECRUITING
Registry status
110 participants
Enrollment target

Study Summary

Evaluating the health outcomes of patients that were enrolled in Joslin's Why WAIT Program. These outcomes include BMI, A1C, lipid profile.

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2006-08
Est. Completion 2027-12
Joslin Diabetes Center

73 total trials

What the registry record for NCT01937845 still lists

NCT01937845 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01937845 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01937845 about?

NCT01937845 is a clinical study titled "Evaluating the Health Outcomes of the Joslin Why WAIT Program". Evaluating the health outcomes of patients that were enrolled in Joslin's Why WAIT Program. These outcomes include BMI, A1C, lipid profile.

What is the current status of trial NCT01937845?

This trial is currently active not recruiting. The enrollment target is 110 participants. The study started on 2006-08. Estimated completion is 2027-12.

Who is sponsoring clinical trial NCT01937845?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01937845, the US trial registry maintained by the National Library of Medicine. NCT01937845 (mid enrollment · none site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.